Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.

Esra Okyar; Leyla  Bozatlı; Işık  Görker

doi:10.5455/PBS.20190128114451

Case Report

PBS. 2019; 9(4): 195-197

doi: 10.5455/PBS.20190128114451

Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.

Esra Okyar, Leyla Bozatlı, Işık Görker.

Abstract
Fragile X Syndrome is a genetic disease defined by cognitive and behavioral characteristics that accompany apparent physical features. Male individuals are affected by this syndrome more severely, and it is the most common cause of mental retardation in men. The most common accompanying psychiatric conditions are mental retardation, autism, Attention Deficit Hyperactivity Disorder (ADHD), anxiety disorder, depression, sleep disorders and aggression. Anxiety, depression, shyness and social withdrawal are more common in female individuals. The diagnosis and treatment of the ADHD and selective mutism in a female adolescent patient who was Fragile X full mutant will be discussed in this case report.

Key words: Fragile X syndrome, ADHD, atomoxetine.

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Esra Okyar Articles by Leyla Bozatlı Articles by Işık Görker
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Okyar E, Bozatlı L, Gorker I. Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. PBS. 2019; 9(4): 195-197. doi:10.5455/PBS.20190128114451

Web Style

Okyar E, Bozatlı L, Gorker I. Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. https://www.pbsciences.org/?mno=28313 [Access: June 22, 2026]. doi:10.5455/PBS.20190128114451

AMA (American Medical Association) Style

Okyar E, Bozatlı L, Gorker I. Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. PBS. 2019; 9(4): 195-197. doi:10.5455/PBS.20190128114451

Vancouver/ICMJE Style

Okyar E, Bozatlı L, Gorker I. Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. PBS. (2019), [cited June 22, 2026]; 9(4): 195-197. doi:10.5455/PBS.20190128114451

Harvard Style

Okyar, E., Bozatlı, . L. . . & Gorker, . I. . . (2019) Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. PBS, 9 (4), 195-197. doi:10.5455/PBS.20190128114451

Turabian Style

Okyar, Esra, Leyla Bozatlı, and Işık Gorker. 2019. Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. Psychiatry and Behavioral Sciences, 9 (4), 195-197. doi:10.5455/PBS.20190128114451

Chicago Style

Okyar, Esra, Leyla Bozatlı, and Işık Gorker. "Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.." Psychiatry and Behavioral Sciences 9 (2019), 195-197. doi:10.5455/PBS.20190128114451

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Okyar, E., Bozatlı, . L. . . & Gorker, . I. . . (2019) Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. Psychiatry and Behavioral Sciences, 9 (4), 195-197. doi:10.5455/PBS.20190128114451

About Psychiatry and Behavioral Sciences

Contact Information

How to cite this article